Reyland M E
Department of Pharmacological Sciences, State University of New York at Stony Brook 11794.
Mol Endocrinol. 1993 Aug;7(8):1021-30. doi: 10.1210/mend.7.8.7694083.
The role of protein kinase C (PKC) in the regulation of basal steroidogenesis and steroid hydroxylase gene expression in Y1 adrenocortical cells was investigated. Treatment of Y1 cells with either staurosporine or calphostin C, inhibitors of PKC, increases steroid hormone production up to 7-fold. Induction of P450-cholesterol side chain cleavage enzyme (SCC) mRNA expression parallels induction of steroidogenesis by the PKC inhibitors. Staurosporine increases expression of a transiently transfected SCC promoter--human growth hormone construct in Y1 cells, indicating that PKC regulates expression of SCC mRNA at the level of transcription. Treatment with staurosporine increases expression of mRNA for two additional steroid synthetic enzymes, P450-11 beta-hydroxylase and 3 beta-hydroxysteroid dehydrogenase. These data indicate that PKC acts as a tonic negative regulator of basal steroidogenesis in Y1 cells by suppressing expression of mRNA encoding the steroid synthetic enzymes. Protein kinase A (PKA) and PKC have reciprocal effects on steroidogenesis and expression of the steroid synthetic enzymes in Y1 cells. However, the results of this study demonstrate that these signaling pathways are not interdependent. Steroid production by Y1 cells treated with (Bu)2cAMP and calphostin C together is equal to the sum of steroid production after treatment with either agent alone. Pretreatment of Y1 cells with Rp-8-Bromo-cAMP, a specific inhibitor of PKA, prevents induction of steroidogenesis by (Bu)2cAMP, but not by staurosporine, indicating that PKC is not dependent on PKA activity. In addition, induction of SCC mRNA expression by staurosporine, in Y1 cells which are defective in activation of PKA (Y1 kin-8), is equivalent to induction in Y1 cells. These data indicate that PKA and PKC regulate basal steroidogenesis through independent effects on expression of the steroid synthetic enzymes.
研究了蛋白激酶C(PKC)在Y1肾上腺皮质细胞基础类固醇生成及类固醇羟化酶基因表达调控中的作用。用PKC抑制剂星形孢菌素或钙磷蛋白C处理Y1细胞,可使类固醇激素产量增加高达7倍。P450 - 胆固醇侧链裂解酶(SCC)mRNA表达的诱导与PKC抑制剂诱导的类固醇生成平行。星形孢菌素可增加Y1细胞中瞬时转染的SCC启动子 - 人生长激素构建体的表达,表明PKC在转录水平调节SCC mRNA的表达。用星形孢菌素处理可增加另外两种类固醇合成酶P450 - 11β - 羟化酶和3β - 羟类固醇脱氢酶的mRNA表达。这些数据表明,PKC通过抑制类固醇合成酶编码mRNA的表达,作为Y1细胞基础类固醇生成的紧张性负调节因子。蛋白激酶A(PKA)和PKC对Y1细胞中的类固醇生成及类固醇合成酶的表达具有相互作用。然而,本研究结果表明这些信号通路并非相互依赖。用(Bu)2cAMP和钙磷蛋白C共同处理的Y1细胞的类固醇产量等于单独用任何一种试剂处理后类固醇产量的总和。用PKA的特异性抑制剂Rp - 8 - 溴 - cAMP预处理Y1细胞,可阻止(Bu)2cAMP诱导的类固醇生成,但不能阻止星形孢菌素诱导的类固醇生成,表明PKC不依赖于PKA活性。此外,在PKA激活缺陷的Y1细胞(Y1 kin - 8)中,星形孢菌素诱导的SCC mRNA表达与Y1细胞中的诱导相当。这些数据表明,PKA和PKC通过对类固醇合成酶表达的独立作用来调节基础类固醇生成。